Researchers at four University of California Health medical centers have begun recruiting participants for a Phase II clinical trial to investigate the safety and efficacy of treating adult patients with COVID-19 with remdesivir, a drug that has shown promising activity against multiple viruses.
With three other UC Health medical centers, NIH-sponsored trial will study whether remdesivir, an investigational antiviral drug, may be a safe and effective agent against the novel coronavirus that causes COVID-19
Some less-than-welcome words and phrases have been added recently to our vocabularies: COVID-19, N95 masks, index case and community spread. Now, of course, there is social distancing. But with the rules changing rapidly on which behaviors will keep us safe from the novel coronavirus, many people are confused about exactly…
As coronavirus spreads around the globe, millions of people are being told to wash their hands. But your hands aren’t the only things you need to keep clean. Researchers have found that the virus can remain on cardboard, copper, plastic and steel from hours to days. Regular cleaning of surfaces…
UCI Health clinicians have launched a clinical trial to test the efficacy of the antiviral drug remdesivir as a potential therapy for COVID-19, the disease caused by the novel coronavirus (SARS-CoV-2) that has reached pandemic levels across the globe. There are no specific therapeutics approved by the Food and Drug…
Partnering with five diagnostics manufacturers, UC San Diego is significantly ramping up testing for COVID-19, projecting capacity to complete up to 1,500 tests daily within two to three weeks.
With COVID-19 restrictions beginning to crimp the region’s blood supply, the UCI Health Blood Donor Center in Orange has expanded its hours of operation to six days a week to boost donations for its patients. The call for more donations comes as the American Red Cross announced a severe blood…
